Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-Differentiated Epithelial Thyroid Cancer
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic
PET-CT fusion scanning after rTSH will be more sensitive to detect disease sites than scanning without rTSH; this information will significantly alter the therapeutic approach in some patients.
Paul W Ladenson, MD
Johns Hopkins University
United States: Institutional Review Board
|M.D. Anderson Cancer Center||Houston, Texas 77030|
|Johns Hopkins Division of Endocrinology & Metabolism||Baltimore, Maryland 21287|